Consistent with the results of immunohistochemistry, western blot of samples from prostate cancer patients showed that CKAP2L expression remarkably upregulated in protein-level with the prostate cancer progression (Fig. 1G). This evidence concerns the gene CKAP2L and Familial prostate cancer.